Allan Brown
Algemeen Directeur bij Glycoscoredx Ltd.
Profiel
Allan Brown is currently the Chief Executive Officer at Glycoscoredx Ltd.
Prior to this, he worked as an Executive Director & COO-Diagnostics Division at Genedrive Plc from 2015 to 2017.
He also worked as a Divisional Managing Director at Hologic Ltd.
Actieve functies van Allan Brown
| Bedrijven | Functie | Begin |
|---|---|---|
Glycoscoredx Ltd.
 Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Algemeen Directeur | 01-09-2020 |
Eerdere bekende functies van Allan Brown
| Bedrijven | Functie | Einde |
|---|---|---|
| GENEDRIVE PLC | Operationeel Directeur | 08-11-2017 |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Corporate Officer/Principal | 01-01-2010 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Commercial Services |
